Voltaren Emulgel gel for external use

Nchi: Armenia

Lugha: Kiingereza

Chanzo: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Viambatanisho vya kazi:

diclofenac (diclofenac diethylamine)

Inapatikana kutoka:

GlaxoSmithKline Consumer Healthcare S.A.

ATC kanuni:

M02AA15

INN (Jina la Kimataifa):

diclofenac (diclofenac diethylamine)

Kipimo:

10mg/g

Dawa fomu:

gel for external use

Vitengo katika mfuko:

20g, 50g and 100g laminated tube

Dawa ya aina:

OTC

Idhini hali ya:

Registered

Idhini ya tarehe:

2019-01-09

Tabia za bidhaa

GSK Consumer Healthcare S.A.,
Switzerland.
Summary of Product Characteristics
Global Labeling
VOLTAREN
Gel
Diclofenac diethylamine 1.16%
SUMMARY OF PRODUCT CHARACTERISTICS
Document status:
FINAL
Release date:
10 Oct 2019
Number of pages:
8
GSK Consumer Healthcare S.A.,
Switzerland.
Summary of Product Characteristics
TABLE OF CONTENTS
1
NAME OF THE MEDICINAL PRODUCT
.......................................................................
3
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
............................................. 3
3
PHARMACEUTICAL FORM
............................................................................................
3
4
CLINICAL PARTICULARS
..............................................................................................
3
4.1
Pharmacotherapeutic group
.....................................................................................
3
4.2
Posology and method of administration
.................................................................. 4
4.3
Contraindications
.....................................................................................................
4
4.4
Special warnings and precautions for use
................................................................ 5
4.5
Interaction with other medicinal products and other forms of
interaction .............. 5
4.6
Pregnancy and lactation
...........................................................................................
5
4.7
Effects on ability to drive and use machines
........................................................... 5
4.8
Undesirable effects
..................................................................................................
6
4.9
Overdose
..................................................................................................................
7
PHARMACOLOGICAL PROPERTIES
...................................................................................
7
4.3
Pharmacodynamic properties
...................................................................................
7